15 million dollar market cap with 5 million in cash for a significant drug, multi billion dollar market and game changer. Going to rally heavily over coming 3-6 months heading into phase 1 studies. AGN was at a 50 million market cap before GLP and 100 million dollar market cap in 2021 on phase 1 studies. Looking very interesting
Ann: Nyrada Commences Key Brain Injury Program Preclinical Study, page-2
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.3¢ |
Change
0.016(28.1%) |
Mkt cap ! $13.09M | |||
| Open | High | Low | Value | Volume |
| 6.0¢ | 7.7¢ | 6.0¢ | $61.01K | 881.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17000 | 7.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.8¢ | 35100 | 1 |
View Market Depth
| Last trade - 15.57pm 03/06/2024 (20 minute delay) ? |
|
|||||
|
Last
7.3¢ |
Change
0.016 ( 28.1 %) |
||||
| Open | High | Low | Volume | ||
| 6.3¢ | 7.6¢ | 6.3¢ | 455079 | ||
| Last updated 15.37pm 03/06/2024 ? | |||||
| NYR (ASX) Chart |